Funded Tech Companies

FibroGen

FibroGen, operating out of San Francisco, received equity investments from Merlin BioMed Group, Rosewood Capital and Apothecary Capital.

Company Overview

Contact Information

Company Background Information

Overview

FibroGen, a research-based biotechfirm, uses its expertise CTGF and HIF biology to discover, develop, and commercialize novel therapeutics.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

11/14/2014

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Enrique Conterno

        

Chief Financial Officer

Pat Cotroneo

        

Chief Medical Officer

Peony Yu

        

Vice President

Elias Kouchakji

        

Vice President

Al Lin

        

Vice President

James Polarek

        

VP - Engineering

Michael Martinelli

        

VP - General Counsel

Michael Lowenstein

        

VP - Human Resources

Richard Farley

        

VP - Operations

Christine Chung

        

VP - Regulatory Affairs

Wayne Frost

        

Company Investors

• Merlin BioMed Group
• Rosewood Capital
• Apothecary Capital
• Duquesne Capital Management
• Adage Capital Management
• Brookside Capital
• Sigma Prime Ventures
• U.S. Venture Partners
• Goldman Sachs

Browse more funded tech companies:

Fibrocor Therapeutics | Fibronostics

Share this article

About Our VC Transaction Database

The company data above is provided by VentureDeal.com, a leading provider of venture capital transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary